Chromoendoscopy With Indigo Carmine vs Virtual Chromoendoscopy (iSCAN 1) for Neoplasia Screening in Patients With Inflammatory Bowel Disease: A Prospective Randomized Study
- 10 November 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 27 (8) , 1256-1262
Abstract
The risk of colon cancer is greater in patients with inflammatory bowel disease (IBD) than in the general population. Chromoendoscopy with dye (CE) is the currently recommended method for detecting dysplasia in screening colonoscopies in IBD patients; however, the role of virtual chromoendoscopy (VC) is not yet well defined. The object of this study was to compare CE and VC with the iSCAN 1 system in the detection of neoplastic lesions in IBD patients. We conducted a prospective, single-center, randomized study in IBD patients who underwent a colonoscopy for colon cancer screening. A total of 129 patients were included and were randomized to undergo a CE (n = 67) or a VC (n = 62). The rates of detection of neoplastic lesions by the 2 endoscopic techniques were compared. A total of 19 neoplastic lesions (9 adenomas and 10 low-grade dysplasias [LGD]) was detected in 16 patients, 12 lesions in the CE group (17.9%), and 7 lesions in the VC group (11.3%; P = 0.2); no differences were found in the overall rate of detection of lesions (neoplastic or nonneoplastic; P = 1). The median of the total examination time and endoscope withdrawal time (minutes) was significantly lower in the VC group than in the CE group (15 vs 20 and 10 vs 14, respectively; P < 0.001). No differences occurred in the rate of detection of neoplastic lesions between CE and VC with iSCAN 1. The time spent on the technique with VC is significantly less than that with CE.Keywords
Funding Information
- MSD, Abbvie, Hospira, Pfizer, Takeda, Janssen, Ferring, Faes Farma, Shire Pharmaceuticals
This publication has 36 references indexed in Scilit:
- Narrow-band imaging as an alternative to chromoendoscopy for the detection of dysplasia in long-standing inflammatory bowel disease: a prospective, randomized, crossover studyGastrointestinal Endoscopy, 2011
- Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)Gut, 2010
- AGA Medical Position Statement on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel DiseaseGastroenterology, 2010
- AGA Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel DiseaseGastroenterology, 2010
- The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented researchGastrointestinal Endoscopy, 2009
- ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel diseaseGastrointestinal Endoscopy, 2006
- Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitisGut, 2004
- The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colonGastrointestinal Endoscopy, 2003
- A reproducible grading scale for histological assessment of inflammation in ulcerative colitisGut, 2000
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987